Your browser doesn't support javascript.
Impact of COVID-19 on Individuals With Irritable Bowel Syndrome and Comorbid Anxiety and/or Depression.
Kamp, Kendra J; Levy, Rona L; Munson, Sean A; Heitkemper, Margaret M.
  • Kamp KJ; Division of Gastroenterology, School of Medicine.
  • Levy RL; School of Social Work.
  • Munson SA; Department of Human Centered Design and Engineering.
  • Heitkemper MM; Department of Biobehavioral Nursing and Health Informatics, School of Nursing, University of Washington, Seattle, WA.
J Clin Gastroenterol ; 56(2): e149-e152, 2022 02 01.
Article in English | MEDLINE | ID: covidwho-1672370
ABSTRACT
GOALS The goal of this study was to describe the influence of the COVID-19 pandemic on ability to engage in activities and the influence on psychological distress and gastrointestinal symptoms among individuals with irritable bowel syndrome (IBS) and comorbid anxiety and/or depression.

BACKGROUND:

Individuals with IBS and comorbid anxiety and/or depression report increased symptoms and decreased quality of life compared with individuals with IBS alone. The current COVID-19 pandemic has the potential to further influence symptoms among individuals with IBS and comorbid anxiety and/or depression. STUDY Individuals who met the Rome-IV IBS criteria and reported mild to severe anxiety and/or depression were included. Participants completed an online survey with questions about anxiety, depression, impact of COVID on activities and symptoms, and demographics.

RESULTS:

Fifty-five individuals participated in the study. The COVID-19 pandemic most commonly influenced their ability to spend time with friends and family, shop for certain types of food, and access health care. Participants also reported increased stress (92%), anxiety (81%), and depressive symptoms (67%). Finally, around half the sample reported increases in abdominal pain (48%), diarrhea (45%), or constipation (44%).

CONCLUSIONS:

The COVID-19 pandemic is related to self-reported increases in psychological distress and gastrointestinal symptoms among individuals with IBS and comorbid anxiety and/or depression. Additional research is needed to intervene on these symptoms.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Irritable Bowel Syndrome / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: J Clin Gastroenterol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Irritable Bowel Syndrome / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: J Clin Gastroenterol Year: 2022 Document Type: Article